LCAV (MM)

LCA-Vision Inc. (Nasdaq: LCAV), a leading provider of laser vision correction services under the LasikPlus brand, announced today that it has implemented Bausch & Lomb�s Zyoptix 100 Hz and Advanced Personalized Technologies at its LasikPlus vision centers across the country. These technologies from Bausch & Lomb combine the benefits of a faster treatment with some of the latest research in the industry. The Advanced Personalized Technology enables the surgeon to uniquely tailor laser vision correction therapy to a patient�s individualized needs and customize the critical part of the treatment area, known as the optical zone, to each patient�s pupil size. �We continue to invest in leading technology that optimizes patient outcomes and satisfaction. Our evaluation of the Zyoptix 100Hz and Advanced Personalized Technologies met the expectations of our Medical Advisory Board, surgeons, vision center staff, and our patients,� said Steve Straus, LCA Vision�s Chief Executive Officer. Forward-Looking Statements This news release may contain forward-looking statements that are subject to risks and uncertainties that may result in actual results to differ materially from current expectations. For a discussion of risks and uncertainties faced, please refer to our filings with the Securities and Exchange Commission including, but not limited to, our Forms 10-K and 10-Q. About LCA-Vision Inc./LasikPlus LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus brand, operates 72 LasikPlus fixed-site laser vision correction centers in 32 states and 56 markets in the United States and a joint venture in Canada. Additional company information is available at www.lca-vision.com and www.lasikplus.com. It's Not Just LASIK. It's LasikPlus!